Treatment Updates for Relapsed/Refractory AML
In round one of their discussion on Acute Myeloid Leukemia, Catherine Lai, MD, and Alice Mims, MD, discuss treatment updates from EHA2024 for recurrent/progressive AML patients.
βΆ 3 mins
